Curis Lifesciences Limited (NSEI: CURIS)
Health Care · Pharmaceuticals · IN
Rs202.00
-2.18% today · +43.3% 1Y
Curis Lifesciences Limited (NSEI: CURIS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $16.88M.
Over the last twelve months the share price has gained 43.3%, trading between 83.60 and 234.75.
Tweenvest scores Curis Lifesciences Limited across four factors: quality 66/100, value 60/100, growth 89/100. Its strongest factor is growth.
CURIS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.88M
- Revenue (TTM)
- $6.47M
- P/E
- 5.44
- EPS
- 37.14
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs234.75
- 52-week low
- Rs83.60
- Avg volume (3M)
- —
- Shares outstanding
- 8.08M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Clearside Biomedical, Inc.DB: CLM0 | $18.34M | €— | — |
| Smruthi Organics LimitedBSE: 540686 | $18.18M | Rs153.75 | -0.55% |
| Quest Laboratories LimitedNSEI: QUESTLAB | $17.42M | Rs102.90 | +12.03% |
| Natural Capsules LimitedBSE: 524654 | $17.36M | Rs159.70 | -1.60% |
| Seoul Pharma Co., LtdKOSDAQ: A018680 | $16.76M | ₩1,933.00 | -0.26% |
| Kimia Biosciences LimitedBSE: 530313 | $16.67M | Rs34.10 | +10.00% |
| PuraPharm Corporation LimitedSEHK: 1498 | $16.50M | HK$0.24 | -5.10% |
| MFC Co., Ltd.KOSE: A432980 | $16.33M | ₩2,555.00 | -2.11% |
Figures last refreshed Oct 11, 2026.